ArticleFrontiers in medicine2026

Direct interleukin-6 inhibitor olokizumab in the treatment of polymyalgia rheumatica: a case series.

Alexey D Meshkov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.